National Gallbladder and Bile Duct Cancer Awareness Month
If you are diagnosed with gallbladder or bile duct cancer, Miami Cancer Institute’s renowned gastrointestinal cancer specialists combine medical expertise and compassionate care to provide the best treatment option for you. Our cancer specialists have access to a range of cutting-edge technologies to diagnose and treat your specific cancer, with the goal of creating a personalized plan that effectively treats your disease.
Early Detection
Newly Diagnosed
-
What Makes Us Better?
-
Expertise With Your Cancer
Clinical Trials
Miami Cancer Institute can provide access to clinical trials not widely available elsewhere. Clinical trials find new ways to treat and diagnose cancer and are ongoing. If an appropriate trial is available, we will talk to you about the benefits and risks.
Physician Spotlight
Horacio Asbun, M.D., FACS, is a surgical oncologist specializing in the treatment of cancers and diseases of the liver, gallbladder, biliary system and pancreas. He is chief of Hepatobiliary and Pancreatic Surgery at Miami Cancer Institute. Throughout his career, Dr. Asbun repeatedly has been named a Top Doctor by U.S. News & World Report and Castle Connelly Ltd. Dr. Asbun is actively involved in clinical research to improve treatment efficacy and patient outcomes. He has published more than 100 scientific articles and 30 book chapters and serves as editor-in-chief of the American College of Surgeons Multimedia Atlas and reviewer for numerous scientific journals. He directs and teaches national courses on surgery and speaks frequently at scientific conferences around the world, with more than 300 presentations to date. He also serves on the boards and committees of several national and international professional societies.
A Breakthrough in Collaborative Care
As Florida's only member of the Memorial Sloan Kettering (MSK) Cancer Alliance, Miami Cancer Institute is part of a deep and functional collaboration that affords patients access to innovative treatments right here at home and ensures that the standards of care developed by our multidisciplinary disease management team match those at MSK.
